Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! The big shareholder groups in Ezion Holdings Limited (SGX:5ME) have power ...
Investigator-sponsored trial of efficacy and tolerability of cabozantinib (cabo) at lower dose: A dose-finding study in men with castration-resistant prostate cancer (CRPC) and bone metastases. This ...
The 5ME cryogenic machining technology transmits liquid nitrogen through a spindle/turret and directly to the cutting edge, at -321°F. Cryogenic machining is not a new concept, but it continues to ...
- ASG-5ME is a Novel Antibody-Drug Conjugate in Evaluation for the Treatment of Pancreatic, Gastric and Prostate Cancers - BOTHELL, Wash.--(BUSINESS WIRE)-- Seattle Genetics, Inc. (NAS: SGEN) today ...
Lockheed adopted 5ME’s cryogenic machining system with an Okuma horizontal center, increasing cutting speeds by 52% with improved surface integrity and part quality, with an estimated 30% cost ...
Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. The phrase "parts machining" conjures up images of ...
BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq: SGEN) today presented interim results from a phase I clinical trial evaluating ASG-5ME for the treatment of metastatic pancreatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results